562 related articles for article (PubMed ID: 25682993)
21. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission.
Shi HY; Chan FK; Tsang SW; Hui YT; Sze SF; Ching JY; Chung T; Iu CY; Lo FH; Shan EH; Li MK; Wu JC; Sung JJ; Ng SC
Inflamm Bowel Dis; 2015 Apr; 21(4):840-6. PubMed ID: 25738375
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Mikami S; Inoue S; Yoshino T; Takeda Y; Kasahara K; Ueno S; Uza N; Kitamura H; Tamaki H; Matsuura M; Inui K; Chiba T
Aliment Pharmacol Ther; 2008 Sep; 28(5):589-97. PubMed ID: 18549460
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
[TBL] [Abstract][Full Text] [Related]
25. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
Farkas K; Rutka M; Golovics PA; Végh Z; Lovász BD; Nyári T; Gecse KB; Kolar M; Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Malickova K; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Palatka K; Lakatos PL; Lukas M; Molnár T
J Crohns Colitis; 2016 Nov; 10(11):1273-1278. PubMed ID: 27106537
[TBL] [Abstract][Full Text] [Related]
27. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
28. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B
Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007
[TBL] [Abstract][Full Text] [Related]
31. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.
López-Palacios N; Mendoza JL; Taxonera C; Lana R; López-Jamar JM; Díaz-Rubio M
Eur J Intern Med; 2011 Dec; 22(6):621-5. PubMed ID: 22075292
[TBL] [Abstract][Full Text] [Related]
32. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
[TBL] [Abstract][Full Text] [Related]
35. Predictors of mucosal healing during induction therapy in patients with acute moderate-to-severe ulcerative colitis.
Motobayashi M; Matsuoka K; Takenaka K; Fujii T; Nagahori M; Ohtsuka K; Iwamoto F; Tsuchiya K; Negi M; Eishi Y; Watanabe M
J Gastroenterol Hepatol; 2019 Jun; 34(6):1004-1010. PubMed ID: 30551266
[TBL] [Abstract][Full Text] [Related]
36. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
[TBL] [Abstract][Full Text] [Related]
37. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
[TBL] [Abstract][Full Text] [Related]
39. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
[TBL] [Abstract][Full Text] [Related]
40. Mucosal interleukin-8 expression as a predictor of subsequent relapse in ulcerative colitis patients with Mayo endoscopic subscore 0.
Uchiyama K; Takagi T; Mizushima K; Asaeda K; Kajiwara M; Kashiwagi S; Toyokawa Y; Hotta Y; Tanaka M; Inoue K; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Yasuda H; Konishi H; Kishimoto M; Naito Y; Itoh Y
J Gastroenterol Hepatol; 2022 Jun; 37(6):1034-1042. PubMed ID: 35233808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
